← SynDRA
ENDOXIFEN
SynDRA canonical compound SYN0021693 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | ESR1 |
| Mechanism of action | estrogen receptor antagonist |
All known targets
Mechanisms of action (all sources)
- ESR1 ANTAGONIST
- ESR1 MODULATOR
Cross-references
Synonyms
- 4-hydroxy-n-desmethyltamoxifen
- N-desmethyl-4-hydroxytamoxifen
- Z-endoxifen
- NSC-749798
- Endoxifen (topical formulation, cancer)
- Endoxifen (topical formulation, cancer), Jina Pharmaceuticals
- Tamoxifen metabolite (topical formulation, cancer), Jina Pharmaceuticals
- Z-Endoxifen
- N-Desmethyl-4-hydroxytamoxifen
- NSC 749798
- ENDOXIFEN [WHO-DD]
- RefChem:590841
- (Z)-Endoxifen
- Endoxifen Z-Isomer
- (E/Z)-Endoxifen
- 4OHNDtam
- Endoxifen (Z-isomer)
- 4-hydroxy-N-desmethyl tamoxifen
- MFCD09840374
- UNII-46AF8680RC
- Endoxifen?
- EndoxifenZ-Isomer
- (Z)-Endoxyfen
- 4-hydroxy-N-desmethyltamoxifen, (Z)-isomer
- Endoxifen(E/Z=1:1)
- orb1305808
- SCHEMBL10107920
- CHEBI:80555
- GTPL10203
- EX-A645
- MHJBZVSGOZTKRH-IZHYLOQSSA-N
- EX-A1970
- BDBM50435003
- EBC-13769
- HY-18719E
- MSK300575
- NSC746494
- NSC749798
- NSC777380
Look up ENDOXIFEN in the interactive SynDRA portal →